Drug intelligence / Profile preview

paracetamol + chlorzoxazone

Development stage
Unknown
Lead developer
Universal Corporation
Modality
Small Molecules
Administration
Oral
01

Overview

Anamol MR is a combination oral pharmaceutical product developed and manufactured by Universal Corporation, primarily marketed in the East African region. It consists of paracetamol (acetaminophen) and chlorzoxazone. Paracetamol serves as an analgesic and antipyretic agent, functioning primarily through the inhibition of prostaglandin synthesis in the central nervous system. Chlorzoxazone is a centrally acting skeletal muscle relaxant that works by inhibiting multisynaptic reflex arcs at the spinal cord and subcortical levels of the brain. This combination is indicated for the symptomatic relief of painful musculoskeletal conditions, including muscle spasms, sprains, strains, and back pain, where both pain relief and muscle relaxation are required.

Brand names
Anamol MR
Other names
acetaminophen + chlorzoxazone
02

Targets

NOS3 (eNOS)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NOS1 (nNOS)PGHS-1 (Prostaglandin G/H Synthase 1)NOS2 (Nitric Oxide Synthase 2)

Beyond the preview

Go deeper on paracetamol + chlorzoxazone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paracetamol + chlorzoxazone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call